Welcome to LookChem.com Sign In|Join Free
  • or
3-iodo-1-methyl-4-nitro-1H-pyrazole is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

186298-52-2

Post Buying Request

186298-52-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

186298-52-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 186298-52-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,6,2,9 and 8 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 186298-52:
(8*1)+(7*8)+(6*6)+(5*2)+(4*9)+(3*8)+(2*5)+(1*2)=182
182 % 10 = 2
So 186298-52-2 is a valid CAS Registry Number.

186298-52-2Downstream Products

186298-52-2Relevant academic research and scientific papers

Direct iodination of 3- and 4-nitropyrazoles with a reagent based on iodine monochloride and silver sulfate

Chaikovskii,Kharlova,Tretyakov,Vasilevsky,Filimonov

, p. 1475 - 1477 (2000)

The reagent obtained from iodine monochloride and silver sulfate in sulfuric acid easily iodinates 1-methyl-3-nitropyrazole under mild conditions to give 4-iodo or 4,5-diiodo derivatives. 1-Methyl-4-nitropyrazole was also directly iodinated with this reagent for the first time.

Nitrodeiodination of 4-iodo-1-methylpyrazoles

Tret'yakov,Vasilevsky

, p. 2581 - 2584 (1996)

4-Iodo-1-methylpyrazoles react with a nitrating mixture at 55°C to give the corresponding 4-nitro-1-methylpyrazoles. The qualitative dependence of the nitrodeiodination rate on the structure of the heterocycles and the reaction conditions was considered.

Compound as well as preparation method and medical application thereof

-

Paragraph 0396-0399, (2020/02/14)

The invention provides a compound as well as a preparation method and medical application thereof, the compound has a structure as shown in a general formula (I), and can also be a tautomer, a mesomer, a raceme, an enantiomer, a diastereoisomer, or a mixture form thereof, or a pharmaceutically acceptable salt thereof. According to the compound with the structure as shown in the general formula (I)provided by the invention, a specific main chain structure and a corresponding substituent group are selected, so that the obtained compound can be used as an arginase inhibitor, is relatively high in activity, and has a potential treatment prospect in various diseases.

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

-

Paragraph 0383, (2017/02/24)

Compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a tautomer, an isomer or a deuterated analog thereof, wherein A, J, R1, R2, R3, R4, R5, R6, R7, R9, X, m and n are as described herein, compositions thereof, and methods and uses thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 186298-52-2